|
Biochemical analyses |
|||||||
| patient |
normal range |
#1 |
#2 |
#3 |
#4 |
#5 |
#6 |
|
|
|||||||
| TNSALP in leukocytes |
2–18 nmol/min/mg protein |
0.1 |
0 |
0.11 |
0.1 |
0.1 |
0.5 |
| PEA in serum/plasma |
0–60 μmol/l |
25 |
Nd |
98 |
6 |
7 |
97 |
| PEA/Cr in urine |
9–25 mmol/mol Cr |
252 |
148 |
250 |
157 |
117 |
155 |
| PLP in plasma |
5–30 ng/ml |
1039 |
408 |
185 |
324 |
446 |
165 |
| Age |
years |
2 |
2,5 |
3 |
7,42 |
9 |
13 |
|
Abbreviations: TNSALP tissue non-specific alkaline phosphatase, PEA phosphoethanolamin, Cr creatinine, PLP pyridoxal phosphate | |||||||
Girschick et al. Orphanet Journal of Rare Diseases 2006 1:24 doi:10.1186/1750-1172-1-24 |
|||||||